{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:40:15Z","timestamp":1791164415596,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.humpath.2012.05.007","type":"journal-article","created":{"date-parts":[[2012,8,30]],"date-time":"2012-08-30T14:15:36Z","timestamp":1346336136000},"page":"39-46","source":"Crossref","is-referenced-by-count":34,"title":["Ki-67 expression in axillary lymph node metastases in breast cancer is prognostically significant"],"prefix":"10.1016","volume":"44","author":[{"given":"Kareem","family":"Tawfik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce F.","family":"Kimler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn K.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ossama","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2012.05.007_bb0005","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/cncr.2820360919","article-title":"Prognosis in breast cancer utilizing histologic characteristics of the primary tumor","volume":"36","author":"Black","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2012.05.007_bb0010","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/bjc.1957.43","article-title":"Histologic grading in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years","volume":"11","author":"Bloom","year":"1957","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2012.05.007_bb0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/028418600430950","article-title":"Histologic grading in breast cancer-reproducibility between seven pathologic departments. South Sweden Breast Cancer Group","volume":"39","author":"Boiesen","year":"2000","journal-title":"Acta Oncol"},{"key":"10.1016\/j.humpath.2012.05.007_bb0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archsurg.1996.01430150079015","article-title":"The new era in breast cancer. Invasion, size and nodal involvement dramatically decreasing as a result of mammography screening","volume":"131","author":"Cady","year":"1996","journal-title":"Arch Surg"},{"key":"10.1016\/j.humpath.2012.05.007_bb0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/path.1711680404","article-title":"Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detects proliferating cells in microwave-processed formalin-fixed paraffin sections","volume":"168","author":"Cattoretti","year":"1992","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2012.05.007_bb0030","doi-asserted-by":"crossref","first-page":"966","DOI":"10.5858\/2000-124-0966-PFIBC","article-title":"Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999","volume":"124","author":"Fitzgibbons","year":"2000","journal-title":"Arch Pathol Lab Medicine"},{"key":"10.1016\/j.humpath.2012.05.007_bb0035","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"Wolff","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2012.05.007_bb0040","first-page":"15","article-title":"Comparison of automated cellular imaging system and manual microscopy for immunohistochemically stained cryostat sections of lung cancer specimens applying p53, Ki-67 and p120","volume":"10","author":"Hilbe","year":"2003","journal-title":"Oncol Rep"},{"key":"10.1016\/j.humpath.2012.05.007_bb0045","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/bjc.1989.200","article-title":"Ki67 immunostaining in primary breast cancer: pathological and clinical associations","volume":"59","author":"Bouzubar","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2012.05.007_bb0050","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2559.2006.02402.x","article-title":"Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index","volume":"48","author":"Jalava","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2012.05.007_bb0055","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/bjc.1998.515","article-title":"MIB-1 labelling index is an independent prognostic marker in primary breast cancer","volume":"78","author":"Jansen","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2012.05.007_bb0060","first-page":"224","article-title":"Ki67 immunoreactivity in breast carcinoma: relationships to prognostic variables and short term survival","volume":"18","author":"Locker","year":"1992","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.humpath.2012.05.007_bb0065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/bjc.1995.30","article-title":"Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival","volume":"71","author":"Pinder","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2012.05.007_bb0070","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/cncr.11188","article-title":"Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors\u2014a surrogate marker?","volume":"97","author":"Trihia","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2012.05.007_bb0075","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","article-title":"Cell cycle analysis of a cell proliferation\u2013associated human nuclear antigen defined by the monoclonal antibody Ki-67","volume":"133","author":"Gerdes","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/j.humpath.2012.05.007_bb0080","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0046-8177(99)90062-X","article-title":"Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count","volume":"30","author":"Lehr","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2012.05.007_bb0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0959-8049(03)00675-0","article-title":"Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients with neoadjuvant anthracycline based chemotherapy","volume":"40","author":"Petit","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2012.05.007_bb0090","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00428-007-0400-0","article-title":"Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count","volume":"450","author":"Tawfik","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2012.05.007_bb0095","first-page":"122","article-title":"Grading ductal carcinoma in situ of the breast using an automated proliferation index","volume":"41","author":"Stasik","year":"2011","journal-title":"Annals Clin Lab Sci."},{"key":"10.1016\/j.humpath.2012.05.007_bb0100","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2012.05.007_bb0105","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/1097-0142(19840215)53:4<999::AID-CNCR2820530429>3.0.CO;2-N","article-title":"Breast self examination practices and breast cancer survival","volume":"53","author":"Foster","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2012.05.007_bb0110","first-page":"171","article-title":"Tumor volume, nodal status and metastasis in breast cancer in women","volume":"76","author":"Atkinson","year":"1986","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2012.05.007_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00428-007-0435-2","article-title":"Ki-67 expression in primary breast carcinomas and their axillary lymph node metastases: clinical implications","volume":"451","author":"Park","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2012.05.007_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1016504129183","article-title":"Ki-67 immunostaining activity is higher in positive axillary lymph nodes than in the primary breast tumor","volume":"75","author":"Buxant","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.humpath.2012.05.007_bb0125","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817712001700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817712001700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T09:49:18Z","timestamp":1687686558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817712001700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0046817712001700"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2012.05.007","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}